(Q38045424)

27 August 2017

Lipoprotein(a): resurrected by genetics (English)

1 reference

27 August 2017

0 references

1 reference

1

1 reference

27 August 2017

G Utermann

2

1 reference

PubMed ID

22998429

27 August 2017

language of work or name

English

0 references

publication date

12 November 2012

1 reference

Journal of Internal Medicine

27 August 2017

1 reference

27 August 2017

273

1 reference

27 August 2017

6-30

1 reference

27 August 2017

1

1 reference

The mysteries of lipoprotein(a)

27 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

A prospective study of lipoprotein(a) and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Genetically elevated lipoprotein(a) and increased risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Genetic variants associated with Lp(a) lipoprotein level and coronary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Lipoprotein(a) as a cardiovascular risk factor: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Convergent evolution of apolipoprotein(a) in primates and hedgehog

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Functional analysis of the chimpanzee and human apo(a) promoter sequences: identification of sequence variations responsible for elevated transcriptional activity in chimpanzee.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

FGF19 signaling cascade suppresses APOA gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Farnesoid X receptor represses hepatic human APOA gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Catalysis of covalent Lp(a) assembly: evidence for an extracellular enzyme activity that enhances disulfide bond formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Lipoprotein(a): intrigues and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

The number of identical kringle IV repeats in apolipoprotein(a) affects its processing and secretion by HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Turnover of lipoprotein (a) in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Identification of megalin/gp330 as a receptor for lipoprotein(a) in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Kringle-containing fragments of apolipoprotein(a) circulate in human plasma and are excreted into the urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Lipoprotein(a) in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Novel insights into Lp(a) physiology and pathogenicity: more questions than answers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Direct interaction of the extracellular matrix protein DANCE with apolipoprotein(a) mediated by the kringle IV-type 2 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Plasma lipoproteins: teaching old dogmas new tricks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Stimulation of interleukin-8 production in human THP-1 macrophages by apolipoprotein(a). Evidence for a critical involvement of elements in its C-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Antifibrinolytic activity of apolipoprotein(a) in vivo: human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Atherogenesis in transgenic mice expressing human apolipoprotein(a)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential pro-inflammatory properties to human apolipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Naturally occurring human plasminogen, like genetically related apolipoprotein(a), contains oxidized phosphatidylcholine adducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Characterization of the enzyme activity of human plasma lipoprotein (a) using synthetic peptide substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Genetics of the quantitative Lp(a) lipoprotein trait. I. Relation of LP(a) glycoprotein phenotypes to Lp(a) lipoprotein concentrations in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Genetics of the quantitative Lp(a) lipoprotein trait. II. Inheritance of Lp(a) glycoprotein phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Genetics of the quantitative Lp(a) lipoprotein trait. III. Contribution of Lp(a) glycoprotein phenotypes to normal lipid variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Molecular basis of congenital lp(a) deficiency: a frequent apo(a) 'null' mutation in caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Serum Lipoprotein(a) Levels in Racially Different Populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Genetic architecture and evolution of the lipoprotein(a) trait

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Molecular definition of the extreme size polymorphism in apolipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Genetic control of lipoprotein(a) concentrations is different in Africans and Caucasians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Genetics of the Lp(a)/apo(a) system in an autochthonous Black African population from the Gabon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

The Apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

A pentanucleotide repeat polymorphism in the 5' control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Polymorphisms in the apolipoprotein(a) gene and their relationship to allele size and plasma lipoprotein(a) concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Single nucleotide polymorphisms in exons of the apo(a) kringles IV types 6 to 10 domain affect Lp(a) plasma concentrations and have different patterns in Africans and Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Variation in LPA is associated with Lp(a) levels in three populations from the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Three single-nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Biological, clinical and population relevance of 95 loci for blood lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Genome-wide association analysis of high-density lipoprotein cholesterol in the population-based KORA study sheds new light on intergenic regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

A comprehensive linkage analysis for myocardial infarction and its related risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Multiple QTL influence the serum Lp(a) concentration: a genome-wide linkage screen in the PROCARDIS study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Genome-wide linkage analysis for identifying quantitative trait loci involved in the regulation of lipoprotein a (Lpa) levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

A genome-wide association study identifies protein quantitative trait loci (pQTLs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6q

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Meta analysis of candidate gene variants outside the LPA locus with Lp(a) plasma levels in 14,500 participants of six White European cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Conventional and Mendelian randomization analyses suggest no association between lipoprotein(a) and early atherosclerosis: the Young Finns Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

LPA and PLG sequence variation and kringle IV-2 copy number in two populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Single-nucleotide polymorphisms in LPA explain most of the ancestry-specific variation in Lp(a) levels in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein(a) levels in African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Lipoprotein metabolism and lipid management in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

The apolipoprotein(a) size polymorphism is associated with nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Apolipoprotein(a) isoform-specific changes of lipoprotein(a) after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Apolipoprotein(a) kringle 4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Decreased urinary apolipoprotein (a) excretion in patients with impaired renal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Lipoprotein(a) in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Lipoprotein(a) and risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Insulin and 2-hour glucose levels are inversely related to Lp(a) concentrations controlled for LPA genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Growth hormone induces low-density lipoprotein clearance but not bile acid synthesis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Sex hormones and lipoprotein(a) concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Update in Lipid Alterations in Subclinical Hypothyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Lipid lowering with thyroid hormone and thyromimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

The thyromimetic T-0681 protects from atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

The liver-selective thyromimetic T-0681 influences reverse cholesterol transport and atherosclerosis development in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Anomalies of lipoprotein pattern and fibrinolysis in acromegalic patients: relation to growth hormone levels and insulin-like growth factor I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome: Impact on lipid-lowering therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Issues concerning the monitoring of statin therapy in hypercholesterolemic subjects with high plasma lipoprotein(a) levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Apolipoprotein E isoforms, serum cholesterol, and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Conditional linkage and genome-wide association studies identify UGT1A1 as a major gene for anti-atherogenic serum bilirubin levels--the Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

A Polymorphism in the Protease-Like Domain of Apolipoprotein(a) Is Associated With Severe Coronary Artery Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Analysis of the apo(a) size polymorphism in Asian Indian populations: association with Lp(a) concentration and coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Lipoprotein(a) and apolipoprotein(a) isoforms: no association with coronary artery calcification in the Dallas Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

A receptor-mediated pathway for cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Sib-pair analysis detects elevated Lp(a) levels and large variation of Lp(a) concentration in subjects with familial defective ApoB

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Nicotinic acid inhibits hepatic APOA gene expression: studies in humans and in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Safety of anacetrapib in patients with or at high risk for coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

21 January 2018

Lipoprotein apheresis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

The NHLBI Twin Study: heritability of apolipoprotein A-I, B, and low density lipoprotein subclasses and concordance for lipoprotein(a)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

Urinary Excretion of Apo(a) Fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02592.X

10.1111/J.1365-2796.2012.02592.X

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference

PubMed ID

22998429